Company Filing History:
Years Active: 1989-2007
Title: Thomas H. Ferguson: Innovator in Pharmaceutical Formulations
Introduction
Thomas H. Ferguson is a notable inventor based in Greenfield, IN (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 6 patents. His work primarily focuses on innovative formulations that enhance the efficacy of medications.
Latest Patents
Among his latest patents is the development of a 2-methyl-thieno-benzodiazepine formulation. This invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation of olanzapine or olanzapine pamoate, along with novel olanzapine pamoate salts or solvates thereof. This formulation aims to improve the delivery and effectiveness of the medication.
Career Highlights
Thomas H. Ferguson is associated with Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation and research. His work at Eli Lilly has allowed him to contribute to advancements in drug formulations that benefit patients worldwide.
Collaborations
Throughout his career, Ferguson has collaborated with esteemed colleagues, including Charles A. Bunnell and Barry A. Hendriksen. These collaborations have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.
Conclusion
Thomas H. Ferguson's contributions to pharmaceutical formulations exemplify the impact of innovation in medicine. His patents reflect a dedication to improving drug delivery systems, ultimately enhancing patient care.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.